(a) Describe the essence of the process by which a pharmaceutical company and the Food and Drug Administration (FDA) function in the development of a new medication, showing understanding of conflicts of interest that sometimes occur.
(b) Describe the Comprehensive Drug Abuse Prevention and Control Act of 1970. Include the criteria for listing a drug as a Schedule 1 - Schedule V controlled substance and give some examples of drugs that are in the Schedule 1 – Schedule V.
(c) Describe the major elements of recent federal approaches to the enforcement of our drug laws, and indicate some of the enormous difficulties and apparently positive consequences associated with those approaches.